Loading current stock analysis…
Loading current stock analysis…
India
As of 18 Sept 2026, 03:30 pm
On September 16, 2026, Fortis Hospotel Limited, a wholly owned subsidiary of Fortis Healthcare, signed definitive agreements with Seth Sunder Lal Jain Charitable Eye Hospital. This agreement allows Fortis Hospotel to provide healthcare services for a new 400+ bedded super specialty hospital in Ashok Vihar, New Delhi. The arrangement includes a 29-year Healthcare Services Agreement where Fortis Hospotel will have exclusive rights to provide specified inpatient services and specialized equipment. Additionally, Fortis will provide a loan of up to ₹567 crore, disbursed over 3-4 years, to the Seth Sunder Lal Jain Charitable Eye Hospital for the hospital's construction and operation. The hospital is expected to commence operations within 3-4 years, subject to necessary approvals.
On September 16, 2026, Fortis Healthcare Limited informed the exchange about filing a Special Leave Petition before the Supreme Court of India. This filing challenges a Delhi High Court judgment dated August 31, 2026, related to a case involving Daiichi Sankyo Company, Limited. The company has disclosed that this petition has no expected financial implications or specified quantum of claims.
Between March 2019 and March 2020, Fortis Healthcare saw a reduction in its Borrowings from ₹2,010 crore to ₹1,594 crore. Capital Work In Progress (CWIP) decreased from ₹450 crore to ₹204 crore, and Investments fell from ₹270 crore to ₹175 crore. Other Assets also reduced from ₹2,290 crore to ₹1,856 crore. Total Assets decreased from ₹11,486 crore to ₹11,036 crore. Equity Capital remained constant at ₹755 crore, while Reserves increased slightly from ₹5,846 crore to ₹5,906 crore. Total Liabilities decreased from ₹11,486 crore to ₹11,036 crore.
Fortis Healthcare's cash flow from operating activities improved significantly, moving from a negative ₹179 crore in March 2019 to a positive ₹172 crore in March 2020. Correspondingly, Free Cash Flow improved from a negative ₹261 crore in March 2019 to a positive ₹35 crore in March 2020. The Cash from Financing Activity decreased from ₹4,257 crore in March 2019 to a negative ₹862 crore in March 2020, and Cash from Investing Activity shifted from a negative ₹3,279 crore in March 2019 to a positive ₹63 crore in March 2020. Net Cash Flow was ₹799 crore in March 2019 and turned negative at ₹627 crore in March 2020.
Fortis Healthcare has demonstrated a Compounded Sales Growth of 18% over the last 5 years and also for the Trailing Twelve Months (TTM). For profits, the Compounded Profit Growth has been 64% over the last 5 years and 16% for the TTM period.
As of 18 Sept 2026, 03:30 pm
Recent drawdown or price variability is high enough to warrant closer monitoring.
Primary driver: Price remains materially below a previous peak
The session opened materially above the previous close, indicating a sharp repricing at the open.
The move may reflect new information; subsequent price follow-through is worth monitoring.
Trading activity was substantially higher than usual and the price closed lower.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
Trading activity was substantially higher than usual and the price closed higher.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
The session traded across a materially wider price range than usual.
Larger price swings can increase short-term uncertainty, especially if they continue.
Latest complete financial results for Q1 FY2027 and comparative quarterly trends.
| Metric | Q1 FY2026-27(Latest) | Q4 FY2025-26 | Q3 FY2025-26 | Q2 FY2025-26 | Q1 FY2025-26 |
|---|---|---|---|---|---|
| Revenue From Operations | PEAK₹2,545.03 crore | ₹2,364.67 crore | ₹2,265.01 crore | ₹2,331.44 crore | ₹2,166.72 crore |
| Finance Costs | ₹80.44 crore | ₹84.28 crore | PEAK₹85.74 crore | ₹74.88 crore | ₹69.57 crore |
| Profit Before Tax | ₹358.80 crore | ₹317.98 crore | ₹262.15 crore | PEAK₹421.72 crore | ₹347.65 crore |
| Tax Expense | ₹90.38 crore | ₹53.01 crore | ₹68.28 crore | PEAK₹96.58 crore | ₹83.79 crore |
| Profit Loss For Period | ₹272.80 crore | ₹271.19 crore | ₹197.40 crore | PEAK₹328.82 crore | ₹266.78 crore |
| Basic Earnings Loss Per Share From Continuing And Discontinued Operations | ₹3.53 per share | ₹3.52 per share | ₹2.57 per share | PEAK₹4.26 per share | ₹3.45 per share |
Revenue from operations rose to ₹2,545 crore in the June 2026 quarter, up 7.6% from the preceding March 2026 quarter (₹2,365 crore) and 17.5% from the year-ago June 2025 quarter (₹2,167 crore). This is the highest quarterly revenue in the last five fiscal quarters, continuing a trend where revenue increased in three of the last four quarter-on-quarter comparisons. The sequential growth accelerated from 4.4% in the March quarter to 7.6% in the June quarter.
Exchange disclosures and regulatory announcements for Fortis Healthcare.
Fortis Healthcare Limited filed a Special Leave Petition before the Hon’ble Supreme Court of India on September 16, 2026, challenging the Delhi High Court's judgment dated August 31, 2026, in the case Daiichi Sankyo Company, Limited vs. Malvinder Mohan Singh And Ors. The petition relates to applications EX.APPL.(OS) 3764/2022, EX.APPL.(OS) 1615/2025, and EX.APPL.(OS) 3763/2022. The company disclosed no expected financial implications or quantum of claims.
On September 16, 2026, Fortis Healthcare Limited's wholly owned subsidiary, Fortis Hospotel Limited, signed definitive agreements with Seth Sunder Lal Jain Charitable Eye Hospital to provide healthcare services to a 400+ bedded super specialty hospital in Ashok Vihar, New Delhi. Under the 29-year Healthcare Services Agreement, FHTL has exclusive rights to provide specified inpatient services and specialized equipment for a service fee, and will provide a loan of INR 567 crore to SLJ Society for construction, disbursed in tranches over 3-4 years. The hospital, owned and operated by SLJ Society, is expected to commence operations in 3-4 years, subject to approvals, and will offer tertiary and quaternary services including oncology, cardiac sciences, and transplants.
On September 16, 2026, Fortis Healthcare Limited's wholly-owned subsidiary, Fortis Hospotel Limited, signed definitive agreements with Seth Sunder Lal Jain Charitable Eye Hospital (SLJ Society) to provide healthcare services for a new 400+ bedded super specialty hospital in Ashok Vihar, New Delhi. Under the terms, SLJ Society will own and construct the facility while Fortis Hospotel Limited secures exclusive rights to operate clinical services for a committed term of 29 years and provides a loan of up to INR 567 crores disbursed over three to four years based on construction progress. The hospital is expected to commence operations within 3-4 years subject to necessary approvals.
On September 16, 2026, Fortis Healthcare's wholly owned subsidiary Fortis Hospotel Limited signed definitive agreements with Seth Sunder Lal Jain Charitable Eye Hospital to provide healthcare services to a new 400+ bed super specialty hospital in Ashok Vihar, New Delhi. Fortis will hold exclusive rights to provide specified inpatient services and specialized equipment under a 29-year Healthcare Services Agreement for an undisclosed service fee. The hospital, to be owned and operated by the society, is expected to start operations in 3-4 years. Under a separate loan agreement, Fortis will provide a phased loan of INR 567 crores to the society for construction and operation. An interest-free refundable security deposit was also provided by Fortis for performance under the agreement.
Fortis Healthcare Limited, through its wholly owned subsidiary Fortis Hospotel Limited (FHTL), entered a Healthcare Services Agreement (HSA) and a Loan Agreement with Seth Sunder Lal Jain Charitable Eye Hospital (SLJ Society) on September 16, 2026. Under the HSA, FHTL has a 29-year exclusive right to provide healthcare services at a new hospital to be built and owned by SLJ Society in Ashok Vihar, Delhi. FHTL will provide a loan of up to INR 567 crore to SLJ Society, disbursed over 3-4 years, for the hospital's construction and operation, secured by appropriate collateral. FHTL will receive a service fee based on a percentage of the hospital's revenue and interest on the loan.
Fortis Healthcare Limited informed stock exchanges of upcoming investor meetings: a Non-Deal Roadshow organized by BNP Paribas on September 21, 2026, and a J.P. Morgan India Conference on September 22, 2026, both in-person group meetings in Mumbai from 9:00 AM to 6:00 PM IST. The schedule is subject to change, and no unpublished price-sensitive information will be shared.
Fortis Healthcare Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Fortis Healthcare Limited announced an in-person group analyst meeting scheduled for September 22, 2026, at 09:00 AM in Mumbai as part of the J.P. Morgan India Conference. The event is designated as an investor conference with Satyendra Chauhan listed as the contact person.
Recent market and company developments associated with Fortis Healthcare.
India Business News: In another twist to the protracted battle against Fortis Healthcare and Japan’s Daiichi Sankyo, the former has filed an appeal in the Supreme Court ag.
At 12:25 IST, the barometer index, the S&P BSE Sensex jumped 281.77 points or 0.38% to 74,618.22. The Nifty 50 index added 128.70 points or 0.55% to 23,346.30.
Fortis Healthcare share price, Fortis Healthcare shares, Fortis Healthcare news, Fortis Healthcare Ashok Vihar, Fortis Hospotel, SLJ Society, Ashok Vihar hospital, Delhi hospital, Fortis Healthcare agreement, healthcare stocks, hospital stocks, Fortis stock
Fortis Healthcare rose 2.94% to Rs 895.85 after the company signed definitive agreements with Seth Sunder Lal Jain Charitable Eye Hospital.
Shares of Inox Wind, Kaynes Technology India, Bandhan Bank and SAIL are banned from F&O trading on 17 September 2026.
Stocks in news, Stocks in buzz, Stocks to buy, Stocks to watch, Infosys, Rentomojo, Karamtara Engineering, ARCIL, Manipal Cards, Mazagon Dock Shipbuilders, Fortis Healthcare, Steamhouse India, Tempsens Instruments, Skyways Air Services, Asset Reconstruction Company India (ARCIL), Alembic Pharmaceuticals, Manipal Payment & Identity Solutions, Juniper Hotels, Highway Infrastructure, Krsnaa Diagnostics, Gujarat Narmada Valley Fertilizers Chemicals, Venus Pipes & Tubes
Stocks to watch today: LCC Projects, Karamtara Engineering, Manipal Payment, Rentomojo, Steamhouse India and Asset Reconstruction Company (India) are slated to list on the bourses today.
On September 16, Indian markets experienced a careful resurgence, with the Nifty and Sensex both moving upwards. This rebound was fueled by increased investments in banking and prominent stocks following a steep drop the previous day. Key players like Infosys and Mazagon Dock are under scrutiny due to recent corporate events.
Comprehensive Section Breakdown for Fortis Healthcare
Strategic Vision: Integrated healthcare delivery services provider in India.
• Network of hospitals and diagnostic services
• Integrated healthcare delivery model
Fortis Healthcare reported a 17.5% year-on-year increase in revenue for the June 2026 quarter, reaching ₹2,545 crore. However, profit before tax rose only 3.2% over the same period, and net profit was essentially flat. The quarter’s main financial story is one of top-line momentum that did not flow through to the bottom line at the same rate, partly because of a sharp sequential increase in tax expense.
Profit before tax (PBT) increased 12.8% sequentially to ₹359 crore, but the year-on-year comparison showed only a 3.2% rise from ₹348 crore. Finance costs increased 15.6% year-on-year to ₹80 crore, a pace close to revenue growth.
Net profit (profit for the period) was ₹273 crore, nearly unchanged from ₹271 crore in the March 2026 quarter and only 2.3% above ₹267 crore a year ago. Basic earnings per share stood at ₹3.53, compared with ₹3.52 in the previous quarter and ₹3.45 a year earlier.
Tax expense jumped 70.5% sequentially from ₹53 crore in the March 2026 quarter to ₹90 crore in the June 2026 quarter. The March quarter figure was the lowest in the last five quarters, making the sequential rise particularly large. On a year-on-year basis, tax expense rose 7.9% from ₹84 crore.
The effective tax rate for the quarter was approximately 25.2% (₹90 crore on PBT of ₹359 crore), up from 16.7% in the March quarter and returning closer to the 24.1% recorded in the same quarter last year. This increase absorbed most of the sequential gain in profit before tax, leaving net profit nearly flat.
Segment revenue from operations matched the consolidated revenue of ₹2,545 crore, indicating that all revenue is attributed to reportable segments. Segment profit before tax was ₹363 crore, slightly above the consolidated PBT of ₹359 crore. The difference of approximately ₹4 crore likely reflects unallocated corporate expenses or eliminations, consistent with the pattern in prior quarters (e.g., March 2026: segment PBT ₹324 crore vs. consolidated ₹318 crore).
The segment PBT margin (segment PBT / segment revenue) was 14.3%, down from 16.2% a year earlier, though higher than the 13.7% recorded in the March quarter. The year-on-year margin compression mirrors the trend observed at the consolidated level.
Fortis Healthcare delivered broad-based revenue growth in the June 2026 quarter, but the benefit did not translate into a proportionate increase in net profit. Profit before tax grew modestly year on year, and net profit was essentially flat as a higher tax expense absorbed the sequential improvement in PBT. The divergence between top-line growth and bottom-line performance was driven by a normalisation of the effective tax rate after a low March quarter and by the fact that profit before tax grew at a much slower pace than revenue.
Category: B2B Services
Agilus Diagnostics provides diagnostic services as a significant part of Fortis's offering.
Key Products & Services: Agilus Diagnostics
Category: Healthcare Services
Fortis operates a network of hospitals across India, offering a range of medical facilities and specialized care.
Key Products & Services: Fortis CDOC • Fortis Escorts Heart Institute • Fortis Escorts Hospital • Fortis Hospital
Core Thesis: The company aims to deliver integrated healthcare by combining medical expertise with compassionate service.
• Clinical Excellence: Fortis is recognized for its clinical excellence in providing healthcare services. • Patient Care: The company focuses on delivering compassionate service alongside medical expertise. • Integrated Delivery: Fortis provides integrated healthcare through its network of hospitals, specialty facilities, and diagnostics.